Simplify Logo

Full-Time

Senior Director

Manufacturing Operations, Gmp

Confirmed live in the last 24 hours

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

Biotechnology
Healthcare

Compensation Overview

$190k - $235kAnnually

+ Equity + Annual Bonus

Senior

Vancouver, BC, Canada

Category
Diagnostics & Laboratory Professionals
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • You have a BS/MS/PhD in biological sciences, engineering or relevant scientific discipline and 12-15+ years of experience in manufacturing of biologics in a GMP setting
  • You have 6+ years of experience in a leadership role managing technical operations, process development, and/or GMP manufacturing operations
  • You have outstanding technical acumen, operational understanding, and GMP compliance in building and managing the new GMP facility
  • You have the passion to build, lead, and mentor a team with the opportunity to leave a lasting legacy on the team, the organization, and the country
  • You have a desire to innovate and push to do things differently
  • You are enthusiastic about applying your expertise in manufacturing operations
  • You are an outstanding communicator and teammate
  • You have experience leading a site through quality audits and/or regulatory inspections and also have experience with CMC regulatory filings
Responsibilities
  • Providing exceptional leadership to the organization, including hiring, mentoring, and developing staff
  • Serving as the senior manufacturing operations leader for the design, construction, and start-up of a new GMP Manufacturing facility for the production of antibody therapeutics. This includes ensuring facility is designed for the future, including the ability to implement innovative manufacturing approaches, add additional capacity, and/or extend into other competency areas (e.g., drug product manufacturing)
  • Working closely with site leadership and quality peers to develop and implement all GMP systems with an emphasis on paperless eSystems
  • Working closely with TechOps peers in process & analytical development to establish a paradigm for efficient process transfer and for SME technical support to manufacturing
  • Ensuring the schedules of the people, facility, equipment, materials, and documents are established and maintained to support the throughput of the facility
  • Identifying and mitigating risks in manufacturing operations that could negatively impact delivery of safe and effect therapies to patients
  • Providing senior leadership to ensure the facility and operation is prepared for all quality audits by AbCellera partners and regulatory inspections by global regulatory agencies and that any findings are addressed promptly
  • Reviewing and approving controlled master documents including standard operating procedures, batch records, material specifications, and validation protocols
  • Budgeting and planning including working closely with the Business Development team to support establishment of global partnerships for antibody discovery-through-GMP

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Stage

Series A

Total Funding

$393.1M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

5%

1 year growth

2%

2 year growth

35%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic collaborations with firms like Viking Global Investors and Biogen expand AbCellera's capabilities and market opportunities.
  • AbCellera's participation in high-profile industry conferences and presentations, such as AACR, showcases its cutting-edge research and strengthens its industry reputation.
  • The company's internal pipeline of therapeutic programs offers potential for significant breakthroughs and new treatments.

What critics are saying

  • The highly competitive and rapidly evolving biopharmaceutical market requires continuous innovation to maintain a competitive edge.
  • The recent resignation of board member Peter Thiel could lead to strategic and governance challenges.

What makes AbCellera Biologics unique

  • AbCellera's proprietary technology platform accelerates antibody discovery, making it faster and more efficient than traditional methods.
  • The company's ability to tackle challenging targets that have been difficult to address with traditional methods sets it apart in the biopharmaceutical market.
  • AbCellera's collaborative business model, which includes partnerships with leading investment firms and biotech companies, enhances its innovation and market reach.

Help us improve and share your feedback! Did you find this helpful?